Penumbra
PEN
#1687
Rank
NZ$21.70 B
Marketcap
NZ$551.91
Share price
-0.20%
Change (1 day)
15.76%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

EPS for Penumbra (PEN)

EPS in 2026 (TTM): NZ$7.44

According to Penumbra's latest financial reports the company's current EPS (TTM) is NZ$7.47. In 2025 the company made an earnings per share (EPS) of NZ$7.79 an increase over its 2024 EPS that were of NZ$0.63.

EPS history for Penumbra from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.44-4.54%
2025NZ$7.791129.73%
2024NZ$0.63
2022NZ-$0.09915-138.6%
2021NZ$0.26-134.09%
2020NZ-$0.75-131.43%
2019NZ$2.40636.84%
2018NZ$0.3346.15%
2017NZ$0.22-73.47%
2016NZ$0.84432.67%
2015NZ$0.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merit Medical
MMSI
NZ$4.02-46.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
NZ-$2.07-127.75%๐Ÿ‡บ๐Ÿ‡ธ USA